Title | RTOG 0924 |
---|---|
Principal Investigator/ Physician | Weisi Yan, MD |
Protocol No. | RTOG 0924 |
Open Date | 02/11/2014 |
Gender | Both |
Cancer Site | Prostate |
Status | Open |
Contact Email | MCI Clinical Trials |
Summary | Protocol Title: "Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial." Inclusion Criteria: Pathologically proven diagnosis of prostatic adenocarcinoma within 180 days of registration; clinically negative lymph nodes as established by imaging within 90 days prior to registration; no evidence of bone metastases; Zubrod performance status 0-1 Exclusion Criteria: Prior invasive (except non-melanoma skin cancer) malignancy unless disease-free for 3 years; previous radical surgery (prostatectomy) or cryosurgery for prostate cancer Clinical Trails.Gov Link: https://clinicaltrials.gov/ct2/show/NCT01368588?term=RTOG+0924&rank=1 |
© 2018 USA Health System